Rebekah Jordan talks with Peter Shone, chief technology officer, iethico, about its latest AI-powered platform that can give clear indications of medicine shortages and predict future supply chain challenges - and what this means for pharmacists.
Christina Smolke, PhD, co-founder and CEO of Antheia, describes how biomanufacturing can provide sustainable, high-quality APIs and KSMs, and de-risk pharmaceutical production by localising and streamlining supply chains.
Yuliyana Manolova, director Business Development Contract Manufacturing at Acino, explores the challenges generics manufacturing in Europe faces, and the actions pharma companies must take to better navigate the current market environment.
Allen Jacques, industry thought leader at Kinaxis, shares that by using technology to improve supply chain visibility and transparency, companies can plan for volatility and identify potential disruption before it occurs,
Cihan Likogullari, head of EMEA at Envirotainer, explores how calculating Total Landed Cost can help pharma companies make more informed decisions about packaging and the hidden costs that may come alongside it.
Despite the carbon footprint from packaging pills to active pharmaceutical ingredient (API) development, Aleiya Lonsdale, head of Event, Lab Innovations, explains how pharma companies in the UK can do their part to help achieve net zero by 2040.
Mahesh Veerina, president and CEO - ParkourSC, describe solutions that could bring improved levels of digitisation, visibility and control to pharmaceutical supply chain environments.
Jon Brewin, business development manager for AutoStore, discusses increasing demands on pharmaceutical supply chains and how automation can improve lead times.
Cihan Likogullari, head of sales EMEA at Envirotainer, explains why there are still barriers to the adoption of active cold-chain containers – and how they can be overcome.
